tiprankstipranks
Aeluma, Inc. (ALMU)
NASDAQ:ALMU
US Market
Want to see ALMU full AI Analyst Report?

Aeluma, Inc. (ALMU) AI Stock Analysis

412 Followers

Top Page

ALMU

Aeluma, Inc.

(NASDAQ:ALMU)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
$15.00
▲(5.49% Upside)
Action:Reiterated
Date:07/30/26
The score is held down primarily by weak financial performance (sharp TTM revenue decline, very large operating losses, and negative free cash flow) and a clearly bearish technical trend (price below all major moving averages). Offsetting factors include a strong liquidity/capital structure and a more constructive strategic outlook from the latest call and corporate updates (non-dilutive contract wins and potential CHIPS funding), but these are not yet translating into sustainable revenue growth or profitability.
Positive Factors
Strong liquidity & low leverage
Aeluma's sizable cash balance and negligible long-term debt provide multi-quarter runway to fund R&D, hires and scale pilot production without immediate dilution. This financial flexibility reduces short-term solvency risk and enables execution on multi-stage commercialization programs and partnership milestones.
Negative Factors
Sharp revenue decline
Aeluma's steep TTM revenue drop signals commercialization timing issues and near-term demand volatility. Persistent low revenue limits operating leverage, slows margin expansion, and makes multi-quarter progress toward sustainable commercial scale and profitability more uncertain for investors and partners.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong liquidity & low leverage
Aeluma's sizable cash balance and negligible long-term debt provide multi-quarter runway to fund R&D, hires and scale pilot production without immediate dilution. This financial flexibility reduces short-term solvency risk and enables execution on multi-stage commercialization programs and partnership milestones.
Read all positive factors

Aeluma, Inc. (ALMU) vs. SPDR S&P 500 ETF (SPY)

Aeluma, Inc. Business Overview & Revenue Model

Company Description
Aeluma, Inc. engineers optoelectronic components primarily for integration into sensing and communication systems. The company fabricates these devices utilizing compound semiconductor materials applied to large-diameter silicon wafers, similar to...
How the Company Makes Money
null...

Aeluma, Inc. Earnings Call Summary

Earnings Call Date:May 13, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Sep 16, 2026
Earnings Call Sentiment Neutral
The call presented a balanced picture: strong technological momentum, expanding commercial interest (notably in AI datacom and SWIR), strategic partnerships and non-dilutive contract wins provide meaningful operational progress and optionality. However, near-term financials are pressured by modest revenue, GAAP losses, negative adjusted EBITDA and timing-related guidance narrowing driven by government contract delays. Customer qualification and scaled production remain future milestones. Given both tangible technical and commercial advances alongside clear financial and timing risks, the overall tone is cautiously optimistic but still early-stage.
Positive Updates
Technology Traction and Differentiation
Aeluma is gaining meaningful interest for its non-indium phosphide approach (InGaAs photodiodes on large-diameter substrates and MOCVD quantum dot lasers). Management highlighted strong attention at OFC and positioning at the intersection of compound semiconductors and scalable microelectronics manufacturing.
Negative Updates
Revenue Slightly Declined and Flat Sequentially
Q3 revenue was $1.2 million, down from $1.3 million in the prior-year Q3 and $1.3 million in the prior quarter (approximately -7.7% year-over-year and -7.7% sequential). Government R&D contracts remained the principal source of revenue.
Read all updates
Q3-2026 Updates
Negative
Technology Traction and Differentiation
Aeluma is gaining meaningful interest for its non-indium phosphide approach (InGaAs photodiodes on large-diameter substrates and MOCVD quantum dot lasers). Management highlighted strong attention at OFC and positioning at the intersection of compound semiconductors and scalable microelectronics manufacturing.
Read all positive updates
Company Guidance
Aeluma updated full‑year revenue guidance to $4.2M–$4.6M (narrowed from $4.0M–$6.0M), citing delays in government contract awards and program start dates that are expected to push some revenue into fiscal 2027; Q3 revenue was $1.2M (vs. $1.3M year‑ago and prior quarter), GAAP net loss was $1.8M (‑$0.10/share), non‑GAAP net loss was $701K (‑$0.04/share), and adjusted EBITDA loss was $911K, while cash and equivalents totaled $37.8M (down $792K from the prior quarter); management noted six new non‑dilutive contracts totaling well over $5M, an ATM allocation of $50M on the existing shelf (no shares sold), and plans to increase spending and R&D as they pursue later‑stage, transition‑oriented government awards and commercial opportunities.

Aeluma, Inc. Financial Statement Overview

Summary
Financials are dominated by heavy losses and cash burn: TTM revenue is modest (~$5.2M) and down sharply (-63%), with very weak profitability (EBIT margin ~-81%, net margin ~-116%) and negative operating/free cash flow (~-$1.7M/~-$1.8M). Offsetting this, the balance sheet is conservatively levered (low debt, debt-to-equity ~0.03) and liquidity is supported by strong cash noted in the latest update.
Income Statement
24
Negative
Balance Sheet
66
Positive
Cash Flow
28
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Dec 2020
Income Statement
Total Revenue5.20M4.67M919.00K193.34K0.000.00
Gross Profit2.17M2.78M300.00K83.94K0.000.00
EBITDA-5.90M-1.89M-4.25M-5.30M-3.63M-11.67K
Net Income-6.00M-3.02M-4.56M-5.38M-3.45M-13.47K
Balance Sheet
Total Assets42.52M19.41M3.84M7.16M5.93M9.08M
Cash, Cash Equivalents and Short-Term Investments37.78M15.74M1.29M5.07M3.74M6.79M
Total Debt1.09M941.00K1.07M458.66K615.69K767.60K
Total Liabilities2.43M1.51M1.57M1.05M831.14K897.56K
Stockholders Equity40.09M17.90M2.28M6.11M5.10M8.19M
Cash Flow
Free Cash Flow-2.22M-1.31M-3.78M-4.31M-3.21M-107.61K
Operating Cash Flow-1.71M-1.15M-3.46M-3.64M-2.25M-1.38K
Investing Cash Flow-514.83K-161.00K-322.00K-672.54K-955.67K-106.23K
Financing Cash Flow24.14M15.76M-4.00K5.64M161.93K145.70K

Aeluma, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$485.65M26.9930.53%3.98%24.07%23.86%
65
Neutral
$4.04B2,579.081.00%45.81%
61
Neutral
$398.61M-151.29-3.79%20.89%-240.91%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
$185.16M-5.48-31.56%7.68%0.83%
48
Neutral
$249.30M-37.32-17.19%43.23%-34.14%
47
Neutral
$157.66M-6.12-77.91%369.39%1.34%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ALMU
Aeluma, Inc.
12.94
-5.26
-28.90%
AXTI
AXT
61.64
58.60
1927.63%
NVEC
NVE
100.40
37.56
59.77%
ATOM
Atomera
4.04
0.73
22.05%
MRAM
Everspin Technologies
16.37
9.62
142.52%
VLN
Valens
1.71
-0.24
-12.31%

Aeluma, Inc. Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Aeluma Secures Proposed CHIPS Act Funding Commitment
Positive
Jul 30, 2026
On July 29, 2026, Aeluma, Inc. announced it had signed a Letter of Intent with the U.S. Department of Commerce for up to $30 million in proposed funding under the CHIPS and Science Act. The contemplated award is intended to support research and de...
Business Operations and StrategyProduct-Related Announcements
Aeluma Showcases Breakthrough 300mm Photonics Manufacturing Platform
Positive
May 19, 2026
Aeluma, Inc. is a semiconductor company focused on next-generation photonics, developing indium gallium arsenide (InGaAs) image sensors and high-speed photodiodes for shortwave infrared applications across mobile and consumer electronics, defense ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 30, 2026